Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Titre (en) » - entrée « primary »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
primarily < primary < primate  Facettes :

List of bibliographic references indexed by primary

Number of relevant bibliographic references: 38.
[0-20] [0 - 20][0 - 38][20-37][20-40]
Ident.Authors (with country if any)Title
000202 (2020) Giorgia Bucciol [Belgique] ; Isabelle Meyts [Belgique]Recent advances in primary immunodeficiency: from molecular diagnosis to treatment
000688 (2019) Rachel E. Simmonds [Royaume-Uni]Transient up-regulation of miR-155-3p by lipopolysaccharide in primary human monocyte-derived macrophages results in RISC incorporation but does not alter TNF expression
000798 (2019) Sydney Grob [États-Unis] ; David M. Mirsky [États-Unis] ; Andrew M. Donson [États-Unis] ; Nathan Dahl [États-Unis] ; Nicholas K. Foreman [États-Unis] ; Lindsey M. Hoffman [États-Unis] ; Todd C. Hankinson [États-Unis] ; Jean M. Mulcahy Levy [États-Unis]Targeting IL-6 Is a Potential Treatment for Primary Cystic Craniopharyngioma
000801 (2019) Ottavia Maria Delmonte ; Luigi Daniele NotarangeloTargeted Therapy with Biologicals and Small Molecules in Primary Immunodeficiencies
000955 (2019) Tomo Nozawa [Japon] ; Kenichi Nishimura [Japon] ; Asami Ohara [Japon] ; Ryoki Hara [Japon] ; Shuichi Ito [Japon]Primary varicella infection in children with systemic juvenile idiopathic arthritis under tocilizumab therapy.
000B42 (2019) Chiara Rizzo ; Lidia La Barbera ; Marianna Lo Pizzo ; Francesco Ciccia ; Guido Sireci ; Giuliana GugginoInvariant NKT Cells and Rheumatic Disease: Focus on Primary Sjogren Syndrome
000C42 (2019) Riccardo Castagnoli [États-Unis, Italie] ; Ottavia Maria Delmonte [États-Unis] ; Enrica Calzoni [États-Unis, Italie] ; Luigi Daniele Notarangelo [États-Unis]Hematopoietic Stem Cell Transplantation in Primary Immunodeficiency Diseases: Current Status and Future Perspectives
000C47 (2019) Ramya Uppuluri [Inde] ; Meena Sivasankaran [Inde] ; Shivani Patel [Inde] ; Venkateswaran Vellaichamy Swaminathan [Inde] ; Kesavan Melarcode Ramanan [Inde] ; Nikila Ravichandran [Inde] ; Balasubramaniam Ramakrishnan [Inde] ; Indira Jayakumar [Inde] ; Lakshman Vaidhyanathan [Inde] ; Revathi Raj [Inde]Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Primary Immune Deficiency Disorders in Children: Challenges and Outcome from a Tertiary Care Center in South India.
000F43 (2019) Jolan E. Walter [États-Unis] ; Irmel A. Ayala [États-Unis] ; Diana Milojevic [États-Unis]Autoimmunity as a continuum in primary immunodeficiency
001251 (2018) Mathilde H. Pioro [États-Unis]Primary Care Vasculitis: Polymyalgia Rheumatica and Giant Cell Arteritis.
001479 (2018) Cristiane De Jesus Nunes-Santos [Brésil, États-Unis] ; Sergio D. Rosenzweig [États-Unis]Bacille Calmette–Guerin Complications in Newly Described Primary Immunodeficiency Diseases: 2010–2017
001715 (2017) Yasir Jamal Sepah [États-Unis] ; Mohammad Ali Sadiq [États-Unis] ; David S. Chu [États-Unis] ; Mark Dacey [États-Unis] ; Ron Gallemore [États-Unis] ; Pouya Dayani [États-Unis] ; Mostafa Hanout [États-Unis] ; Muhammad Hassan [États-Unis] ; Rubbia Afridi [États-Unis] ; Aniruddha Agarwal [États-Unis] ; Muhammad Sohail Halim [États-Unis] ; Diana V. Do [États-Unis] ; Quan Dong Nguyen [États-Unis]Primary (Month-6) Outcomes of the STOP-Uveitis Study: Evaluating the Safety, Tolerability, and Efficacy of Tocilizumab in Patients With Noninfectious Uveitis.
001910 (2017) Pandiarajan Vignesh [Inde] ; Amit Rawat [Inde] ; Surjit Singh [Inde]An Update on the Use of Immunomodulators in Primary Immunodeficiencies.
001A72 (2016) Nicholas Holdgate [États-Unis] ; E. Wiliam St. Clair [États-Unis]Recent advances in primary Sjogren's syndrome
001B26 (2016) Carlo Salvarani [États-Unis] ; Nicol Pipitone ; Gene G. HunderManagement of primary and secondary central nervous system vasculitis.
001D44 (2016) Andreas Bayer [Allemagne] ; Justus Lammel [Allemagne] ; Franziska Rademacher [Allemagne] ; Justus Gro [Allemagne] ; Markus Siggelkow [Allemagne] ; Sebastian Lippross [Allemagne] ; Tim Klüter [Allemagne] ; Deike Varoga [Allemagne] ; Mersedeh Tohidnezhad [Allemagne] ; Thomas Pufe [Allemagne] ; Jochen Cremer [Allemagne] ; Regine Gl Ser [Allemagne] ; Jürgen Harder [Allemagne]Platelet‐released growth factors induce the antimicrobial peptide human beta‐defensin‐2 in primary keratinocytes
001E34 (2015) Valérie Devauchelle-Pensec [France] ; Jacques-Eric Gottenberg [France] ; Sandrine Jousse-Joulin [France] ; Jean-Marie Berthelot [France] ; Aleth Perdriger [France] ; Eric Hachulla [France] ; Pierre Yves Hatron [France] ; Xavier Puechal [France] ; Véronique Le Guern [France] ; Jean Sibilia [France] ; Laurent Chiche [France] ; Vincent Goeb [France] ; Olivier Vittecoq [France] ; Claire Larroche [France] ; Anne Laure Fauchais [France] ; Gilles Hayem [France] ; Jacques Morel [France] ; Charles Zarnitsky [France] ; Jean Jacques Dubost [France] ; Philippe Dieudé [France] ; Jacques Olivier Pers [France] ; Divi Cornec [France] ; Raphaele Seror [France] ; Xavier Mariette [France] ; Emmanuel Nowak [France] ; Alain Saraux [France]Which and How Many Patients Should Be Included in Randomised Controlled Trials to Demonstrate the Efficacy of Biologics in Primary Sjögren’s Syndrome?
001E88 (2015) Hiroki Goto [Japon] ; Eriko Kudo ; Ryusho Kariya ; Manabu Taura ; Harutaka Katano ; Seiji OkadaTargeting VEGF and interleukin-6 for controlling malignant effusion of primary effusion lymphoma.
001F96 (2015) Freya A. Goumas [Allemagne] ; Reinhild Holmer [Allemagne] ; Jan-Hendrik Egberts [Allemagne] ; Artur Gontarewicz [Allemagne] ; Carola Heneweer [Allemagne] ; Ulf Geisen [Allemagne] ; Charlotte Hauser [Allemagne] ; Maria-Margarete Mende [Allemagne] ; Karen Legler [Allemagne] ; Christoph Röcken [Allemagne] ; Thomas Becker [Allemagne] ; Georg H. Waetzig [Allemagne] ; Stefan Rose-John [Allemagne] ; Holger Kalthoff [Allemagne]Inhibition of IL-6 signaling significantly reduces primary tumor growth and recurrencies in orthotopic xenograft models of pancreatic cancer.
002033 (2015) Clare Oni [Royaume-Uni] ; Sheryl Mitchell ; Katherine James ; Wan-Fai Ng ; Bridget Griffiths ; Victoria Hindmarsh ; Elizabeth Price ; Colin T. Pease [Royaume-Uni] ; Paul Emery [Royaume-Uni] ; Peter Lanyon ; Adrian Jones ; Michele Bombardieri [Royaume-Uni] ; Nurhan Sutcliffe [Royaume-Uni] ; Costantino Pitzalis [Royaume-Uni] ; John Hunter ; Monica Gupta ; John Mclaren ; Annie Cooper ; Marian Regan ; Ian Giles [Royaume-Uni] ; David Isenberg [Royaume-Uni] ; Vadivelu Saravanan ; David Coady ; Bhaskar Dasgupta ; Neil Mchugh ; Steven Young-Min ; Robert Moots ; Nagui Gendi ; Mohammed Akil ; Francesca Barone [Royaume-Uni] ; Ben Fisher [Royaume-Uni] ; Saaeha Rauz [Royaume-Uni] ; Andrea Richards [Royaume-Uni] ; Simon J. Bowman [Royaume-Uni]Eligibility for clinical trials in primary Sjögren’s syndrome: lessons from the UK Primary Sjögren’s Syndrome Registry
002137 (2015) J. Payet [France] ; R. Belkhir [France] ; J E Gottenberg [France] ; E. Bergé [France] ; F. Desmoulins [France] ; O. Meyer [France] ; X. Mariette [France] ; R. Seror [France]ACPA-positive primary Sjögren's syndrome: true primary or rheumatoid arthritis-associated Sjögren's syndrome?

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "primary" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "primary" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    primary
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021